161 results on '"Neeland, Ian J."'
Search Results
2. The Urban Environment and Cardiometabolic Health
3. Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study
4. Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial
5. Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes
6. The transiency of metabolically healthy obesity: Metabolic decline and atherosclerotic risk
7. Association of Hepatic Triglyceride Content With Cardiac Structure and Function Among Community-Dwelling Adults
8. The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study
9. Second-Year Results from CINEMA: A Novel, Patient-Centered, Team-Based Intervention for Patients with Type 2 Diabetes or Prediabetes at High Cardiovascular Risk
10. Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations
11. Effects of an oral biodegradable device used for 12 weeks on weight reduction, cardiovascular risk factors, satiety, snacking, and meal size
12. Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles
13. Body Fat Distribution, Diabetes Mellitus, and Cardiovascular Disease: an Update
14. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study
15. Adipo-cardiology: The next frontier in cardiovascular disease
16. Leisure time versus occupational physical activity for cardiometabolic risk
17. Is Metabolically Healthy Obesity Really Healthy for the Heart?
18. Editorial commentary: Weight loss for cardiovascular disease prevention – is semaglutide the answer?
19. Diabetes
20. List of Contributors
21. Disparities in Statin Prescription Among Patients with Severe Hypercholesterolemia in an Integrated Healthcare System
22. AN OBSERVATIONAL ANALYSIS OF 7,000 PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA: IDENTIFYING AN AGE-TREATMENT GAP IN CARDIOVASCULAR RISK REDUCTION
23. Older black race is a risk factor for metabolic syndrome in cutaneous lupus erythematosus
24. Food insecurity and atherosclerotic cardiovascular disease risk in adults with diabetes
25. Coronary artery calcium scoring as a tool for risk stratification in patients with an elevated lipoprotein(a) level
26. Impact of low/no-charge coronary artery calcium scoring on statin eligibility and outcomes in women: The CLARIFY study
27. Associations of liver fat content with cardiometabolic phenotypes and outcomes in a multi‐ethnic population: Results from the Dallas Heart Study
28. Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry
29. Time-Varying Cardiovascular Effects of Finerenone in Diabetic Kidney Disease
30. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy
31. Physical activity and fitness vs adiposity and weight loss for the prevention of cardiovascular disease and cancer mortality
32. Lessons Learned From a Patient‐Centered, Team‐Based Intervention for Patients With Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results From the CINEMA Program
33. Contemporary utilization of GLP1 receptor agonists and SGLT2 inhibitors in patients with diagnosed type 2 diabetes and cardiovascular disease in the United States
34. Body Composition and Pulmonary Diseases
35. Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
36. Su1384: ASSOCIATION OF HEPATIC TRIGLYCERIDE CONTENT WITH CARDIAC STRUCTURE AND FUNCTION AMONG COMMUNITY-DWELLING ADULTS: FINDINGS FROM THE DALLAS HEART STUDY
37. Taking the Obesity Paradox to New Heights in Cerebral Atherosclerosis
38. Abstract P175: Combined Metabolic Health And Obesity Status Is Associated With Markers Of High-Density Lipoprotein Metabolism: Dallas Heart Study
39. A randomized clinical trial evaluating the effect of empagliflozin on triglycerides in obese adults: Role of visceral fat
40. CORONARY ARTERY CALCIUM SCORING FOR RISK ASSESSMENT IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
41. Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
42. Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank
43. Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts
44. Evaluation of the Value of Waist Circumference and Metabolomics in the Estimation of Visceral Adipose Tissue
45. Cardiogenic shock temporally associated with COVID-19 vaccination after prior COVID-19 infection: A case report
46. Adipose Tissue Inflammation and Cardiovascular Disease: An Update
47. Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
48. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
49. Abstract 12439: Sex-Specific Associations Between Adipose Depots With Subclinical Coronary Atherosclerosis and Cardiovascular Risk
50. Abstract 13892: The Impact of Cardio-Renal Comorbidities on Medical Spend in Patients With Diabetes: A Contemporary Analysis of a Large Accountable Care Organization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.